#ivcfilter

The global inferior vena cava (IVC) filter market is to grow steadily during the forecast period. The growth can be attributed to the high prevalence of Pulmonary Embolism (PE) across the world. According to the WHO, the incidence of PE is between 0.75 and 2.69 per 1,000 individuals per year globally. Epidemiological studies reported that more than 1 million people in the US are affected by PE annually, with approximately 100,000–200,000 PE fatalities. The overall healthcare expenditure on PE is estimated to be over $1.5 billion per year in the US alone. Factors such as the growth in the aging population, consumption of junk foods, and the growth in the smoking population, the rise in lifestyle-related diseases, including obesity are increasing the prevalence of PE at a steady rate. Hence, the growing demand for optional & retrievable IVC filters and the increasing availability of innovative approaches for placement/retrieval are expected to drive the growth of the global inferior vena cava (IVC) filter market. Moreover, the development of advanced devices, including bioconvertible, convertible, and combination filters and central venous catheters is another primary factor driving the uptake of inferior vena cava (IVC) filters worldwide.

Read more : https://www.arizton.com/market-reports/inferior-vena-cava-filter-market